Total Payments
$1,627
2024 Payments
$317.18
Companies
13
Transactions
41
Medicare Patients
1,559
Medicare Billing
$686,392
Payment Breakdown by Category
Food & Beverage$1,473 (90.5%)
Education$154.16 (9.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,473 | 34 | 90.5% |
| Education | $154.16 | 7 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $310.60 | 5 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $273.51 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $248.96 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $238.00 | 8 | $0 (2024) |
| Vifor Pharma, Inc. | $158.27 | 5 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $151.35 | 1 | $0 (2023) |
| AbbVie, Inc. | $92.49 | 1 | $0 (2017) |
| SHIELD THERAPEUTICS INC | $51.25 | 1 | $0 (2024) |
| Travere Therapeutics, Inc. | $31.91 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $21.23 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $317.18 | 9 | Amgen Inc. ($185.68) |
| 2023 | $319.87 | 10 | Mallinckrodt Hospital Products Inc. ($151.35) |
| 2022 | $251.95 | 10 | Vifor Pharma, Inc. ($133.31) |
| 2021 | $18.74 | 1 | Fresenius USA Marketing, Inc. ($18.74) |
| 2020 | $12.86 | 1 | AKEBIA THERAPEUTICS INC ($12.86) |
| 2019 | $514.37 | 8 | Otsuka America Pharmaceutical, Inc. ($227.87) |
| 2017 | $191.91 | 2 | Fresenius USA Marketing, Inc. ($99.42) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Amgen Inc. | Aranesp (Biological), EPOGEN | Food and Beverage | In-kind items and services | $141.09 | General |
| Category: Nephrology | ||||||
| 08/28/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $51.25 | General |
| Category: Hematology | ||||||
| 07/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Inflammation | ||||||
| 03/21/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.17 | General |
| 03/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Education | In-kind items and services | $10.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Education | In-kind items and services | $5.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: KRYSTEXXA | ||||||
| 10/17/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $13.42 | General |
| 07/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $151.35 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.49 | General |
| 03/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/31/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 01/12/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Hyperkalemia | ||||||
| 01/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $6.38 | General |
| 10/26/2022 | Vifor Pharma, Inc. | — | Education | In-kind items and services | $6.38 | General |
| 10/25/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Hyperkalemia | ||||||
| 10/18/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: NEPHROLOGY | ||||||
| 09/28/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 409 | 1,290 | $480,643 | $149,320 |
| 2022 | 8 | 308 | 1,261 | $316,309 | $138,685 |
| 2021 | 9 | 389 | 1,646 | $437,090 | $198,505 |
| 2020 | 8 | 453 | 1,918 | $493,600 | $199,882 |
Total Patients
1,559
Total Services
6,115
Medicare Billing
$686,392
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 175 | $158,725 | $50,757 | 32.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 133 | 633 | $130,398 | $41,716 | 32.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 75 | 157 | $48,513 | $15,550 | 32.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 45 | $33,885 | $10,816 | 31.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 65 | $29,315 | $9,260 | 31.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 12 | 33 | $24,882 | $7,982 | 32.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 35 | 99 | $27,225 | $5,759 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 52 | $17,160 | $4,091 | 23.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 31 | $10,540 | $3,390 | 32.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 32 | 206 | $123,600 | $60,818 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 113 | 673 | $80,760 | $40,210 | 49.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 40 | 205 | $56,375 | $12,470 | 22.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 23 | 38 | $18,774 | $9,274 | 49.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $12,800 | $5,305 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 35 | $7,525 | $3,552 | 47.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 31 | $9,300 | $3,540 | 38.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 41 | $7,175 | $3,516 | 49.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 35 | 271 | $162,600 | $82,672 | 50.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 135 | 841 | $100,920 | $51,351 | 50.9% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 12 | 60 | $33,000 | $15,172 | 46.0% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 52 | 239 | $65,725 | $14,796 | 22.5% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 26 | 53 | $26,500 | $13,417 | 50.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 51 | 57 | $17,100 | $6,618 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 34 | $13,600 | $5,662 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 43 | $9,245 | $4,608 | 49.8% |
About Dr. Constantine Delis, DO
Dr. Constantine Delis, DO is a Nephrology healthcare provider based in Melrose Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003892043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constantine Delis, DO has received a total of $1,627 in payments from pharmaceutical and medical device companies, with $317.18 received in 2024. These payments were reported across 41 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,473).
As a Medicare-enrolled provider, Delis has provided services to 1,559 Medicare beneficiaries, totaling 6,115 services with total Medicare billing of $686,392. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Melrose Park, IL
- Active Since 12/21/2005
- Last Updated 07/28/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1003892043
Products in Payments
- Velphoro (Drug) $232.35
- ACTHAR (Biological) $151.35
- LOKELMA (Drug) $144.59
- Aranesp (Biological) $141.09
- JYNARQUE (Drug) $126.56
- Parsabiv (Biological) $124.92
- SAMSCA (Drug) $122.40
- FARXIGA (Drug) $93.41
- Viekira (Drug) $92.49
- Veltassa (Drug) $53.67
- ACCRUFER (Drug) $51.25
- KRYSTEXXA (Biological) $37.49
- TAVNEOS (Drug) $28.33
- LUPKYNIS (Drug) $18.99
- Kerendia (Drug) $17.46
- AURYXIA (Drug) $12.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Melrose Park
Rizwan Moinuddin, Do, DO
Nephrology — Payments: $23,317
Nephrology $23,317
George Naratadam, D.o, D.O
Nephrology — Payments: $3,850
Nephrology $3,850
Martin Finn, Md, MD
Nephrology — Payments: $1,555
Nephrology $1,555
Dr. Neetha Dhananjaya, M.d, M.D
Nephrology — Payments: $1,278
Nephrology $1,278
David Kracker, Md, MD
Nephrology — Payments: $886.12
Nephrology $886.12
Dr. Rajani Kosuri, M.d, M.D
Nephrology — Payments: $270.02
Nephrology $270.02